The FMCG firm's Q2 net profit jumped 125% YoY on robust revenue, yet a surge in receivables left operating cash flow minimal, highlighting a key risk.
Healthy Life Agritec reported a 125% surge in Q2 FY27 net profit to ₹1.78 crore, driven by a 57% revenue jump. However, operating cash flow remained negligible as trade receivables ballooned, raising questions about earnings quality.
For a company sourcing milk and chicken directly from farmers, growth is often a story of volume and price. Healthy Life Agritec’s September quarter delivered that, with revenue leaping 57% year-on-year. Yet the headline profit surge of 125% masks a tension between reported earnings and the cash actually reaching the company.
Revenue rose to ₹75.95 crore from ₹48.24 crore a year ago, while net profit more than doubled to ₹1.78 crore. Sequentially, both top and bottom lines grew, with profit up 27% from the June quarter. The net profit margin improved to 2.3%, up 70 basis points from last year.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 75.95YoY +57% | 69.52 | 48.24 |
| Profit (₹ Cr) | 1.78YoY +125% | 1.40 | 0.79 |
| Net Profit Margin | 2.3%YoY +44% | 2.0% | 1.6% |
The profit jump outpaced revenue due to operating leverage and cost control. A report by ScanX noted employee benefits expense fell, helping margins despite higher finance costs. However, a stark divergence emerged in cash generation.
For the half-year ended September, consolidated profit before tax doubled to ₹4.28 crore. Yet net cash from operations was a minimal ₹0.51 lakh, according to the same report. This gap is attributed to a substantial increase in trade receivables, which surged by ₹96.45 crore over the six-month period.
The market has shown deep skepticism. Despite the profit growth, the stock hit a 52-week low of ₹4.75 on November 17, as reported by MarketsMojo. It trades at a PE of 5.4, an 88% discount to the industry average of 44.1.
Live Chart
· HEALTHYLIFE
(BSE)
ISIN: INE0L3501015
This discount reflects concerns beyond a single quarter. The company’s transition to food processing, supported by a new automated facility, brings execution risks. Its related-party manufacturing deal, flagged in the annual report, adds another layer for investors to watch.
Key Points
This quarter presents a classic case of growth versus quality. The impressive profit jump is real, aided by a favorable commodity price environment for milk in Karnataka. Yet the ballooning receivables indicate revenue is being booked faster than cash is collected, a working capital strain that cannot persist indefinitely.
The path to closing the massive valuation gap lies in demonstrating that this sales growth is sustainable and collectible. Investors will need to see receivables stabilize and cash conversion improve in the coming quarters, proving that the top-line momentum is built on a solid financial foundation.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.